Xuan Li

机构：Nankai University, Tianjin Medical University Eye Hospital, Tianjin Medical University, Yangzhou University · ORCID：0000-0003-1052-4222

发表论文 136 篇 · 总被引 2466 次 · h-index 25

代表论文

• Bystander effect in antibody-drug conjugates: Navigating the fine line in tumor heterogeneity (2025 · Critical Reviews in Oncology/Hematology · 被引 23)
• Pirfenidone for grade 2 and grade 3 radiation-induced lung injury: a multicentre, open-label, randomised, phase 2 trial (2025 · The Lancet Oncology · 被引 10)
• A cGAS-STING pathway activating cobalt(III) cyclam prodrug for combined chemotherapy and immunotherapy of breast cancer (2025 · Journal of Controlled Release · 被引 10)
• Combined and interaction effects of outdoor and reading time on myopia onset: evidence from over 210 000 schoolchildren in China (2025 · Journal of Global Health · 被引 9)
• Fecal microbiota transplantation for refractory chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation: a pilot open-label, non-placebo-controlled study (2025 · BMC Medicine · 被引 7)
• Lycium barbarum glycopeptide reduces inflammation and fibrosis in corneal injury by modulating the NF-κB/NLRP3/IL-1 β signaling pathway and microRNA-21a-5p/SMAD7 (2025 · Experimental Eye Research · 被引 5)